HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice.

Abstract
Obesity is a central feature of the metabolic syndrome and is associated with increased risk for insulin resistance and typeII diabetes. Here, we investigated the contribution of human apoliproteinE3 and mouse apoliproteinE to the development of diet-induced obesity in response to western-type diet. Our data show that apolipoproteinE contributes to the development of obesity and other related metabolic disorders, and that human apolipoproteinE3 is more potent than mouse apolipoproteinE in promoting obesity in response to western-type diet. Specifically, we found that apolipoproteinE3 knock-in mice fed western-type diet for 24 weeks became obese and developed hyperglycemia, hyperinsulinemia, hyperleptinemia, glucose intolerance and insulin resistance that were more severe than in C57BL/6 mice. In contrast, apolipoproteinE-deficient mice fed western-type diet for the same period were resistant to diet-induced obesity, had normal plasma glucose, leptin and insulin levels, and exhibited normal responses to glucose tolerance and insulin resistance tests. Furthermore, low-density lipoprotein receptor-deficient mice were more sensitive to the development of diet-induced obesity and insulin resistance than apolipoprotein E-deficient mice, but were still more resistant than C57BL/6 mice, raising the possibility that low-density lipoprotein receptor mediates, at least in part, the effects of apolipoproteinE on obesity. Taken together, our findings suggest that, in addition to other previously identified mechanisms of obesity, apolipoproteinE and possibly the chylomicron pathway are also important contributors to the development of obesity and related metabolic dysfunctions in mice.
AuthorsIordanes Karagiannides, Rami Abdou, Aikaterini Tzortzopoulou, Peter J Voshol, Kyriakos E Kypreos
JournalThe FEBS journal (FEBS J) Vol. 275 Issue 19 Pg. 4796-809 (Oct 2008) ISSN: 1742-464X [Print] England
PMID18754772 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoprotein E3
  • Apolipoproteins E
  • Blood Glucose
  • Dietary Fats
  • Insulin
  • Leptin
  • Lipids
  • Receptors, LDL
  • Triglycerides
Topics
  • Adipose Tissue (metabolism)
  • Animals
  • Apolipoprotein E3 (physiology)
  • Apolipoproteins E (deficiency, physiology)
  • Blood Glucose (metabolism)
  • Body Composition
  • Dietary Fats (administration & dosage, adverse effects)
  • Female
  • Glucose Intolerance (etiology)
  • Humans
  • Insulin (blood)
  • Insulin Resistance (physiology)
  • Leptin (blood)
  • Lipids (blood)
  • Liver (metabolism)
  • Mice
  • Obesity (etiology, physiopathology)
  • Receptors, LDL (deficiency, physiology)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: